A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial).
Hutchinson PJ, Edlmann E, Hanrahan JG, Bulters D, Zolnourian A, Holton P, Suttner N, Agyemang K, Thomson S, Anderson IA, Al-Tamimi Y, Henderson D, Whitfield P, Gherle M, Brennan PM, Allison A, Thelin EP, Tarantino S, Pantaleo B, Caldwell K, Davis-Wilkie C, Mee H, Warburton EA, Barton G, Chari A, Marcus HJ, Pyne S, King AT, Belli A, Myint PK, Wilkinson I, Santarius T, Turner C, Bond S, Kolias AG; British Neurosurgical Trainee Research Collaborative and Dex-CSDH Trial Collaborators.
Hutchinson PJ, et al. Among authors: turner c.
Health Technol Assess. 2024 Mar;28(12):1-122. doi: 10.3310/XWZN4832.
Health Technol Assess. 2024.
PMID: 38512045
Free PMC article.
Clinical Trial.